Free Trial
NASDAQ:BIVI

BioVie (BIVI) Stock Price, News & Analysis

BioVie logo
$1.48 -0.14 (-8.64%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$1.54 +0.06 (+4.05%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About BioVie Stock (NASDAQ:BIVI)

Key Stats

Today's Range
$1.46
$1.64
50-Day Range
$1.48
$10.70
52-Week Range
$1.46
$75.00
Volume
355,666 shs
Average Volume
456,017 shs
Market Capitalization
$11.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

BioVie Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

BIVI MarketRank™: 

BioVie scored higher than 16% of companies evaluated by MarketBeat, and ranked 894th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BioVie is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BioVie is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BioVie has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about BioVie's valuation and earnings.
  • Percentage of Shares Shorted

    8.15% of the float of BioVie has been sold short.
  • Short Interest Ratio / Days to Cover

    BioVie has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BioVie has recently decreased by 13.55%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    BioVie does not currently pay a dividend.

  • Dividend Growth

    BioVie does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.15% of the float of BioVie has been sold short.
  • Short Interest Ratio / Days to Cover

    BioVie has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BioVie has recently decreased by 13.55%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    BioVie has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for BioVie this week, compared to 1 article on an average week.
  • Search Interest

    Only 3 people have searched for BIVI on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    17 people have added BioVie to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, BioVie insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.39% of the stock of BioVie is held by insiders.

  • Percentage Held by Institutions

    Only 4.59% of the stock of BioVie is held by institutions.

  • Read more about BioVie's insider trading history.
Receive BIVI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIVI Stock News Headlines

BioVie (NASDAQ:BIVI) Rating Lowered to "Sell" at Wall Street Zen
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
See More Headlines

BIVI Stock Analysis - Frequently Asked Questions

BioVie's stock was trading at $20.00 at the start of the year. Since then, BIVI stock has decreased by 92.6% and is now trading at $1.48.

BioVie Inc. (NASDAQ:BIVI) posted its quarterly earnings data on Monday, May, 12th. The company reported ($1.50) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.20) by $1.70.

Shares of BioVie reverse split before market open on Monday, July 7th 2025.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, July 6th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Top institutional shareholders of BioVie include Jane Street Group LLC (3.32%) and XTX Topco Ltd (2.33%). Insiders that own company stock include Steve Gorlin and Cuong V Do.
View institutional ownership trends
.

Shares of BIVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioVie investors own include ARMOUR Residential REIT (ARR), AGNC Investment (AGNC), Hon Hai Precision Industry Co., Ltd. Sponsored GDR (HNHPF), Main Street Capital (MAIN), Ares Capital (ARCC) and PIMCO Dynamic Income Fund (PDI).

Company Calendar

Last Earnings
5/12/2025
Today
8/28/2025
Next Earnings (Estimated)
9/29/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BIVI
CIK
1580149
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($79.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.54 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-89.02%
Return on Assets
-75.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.10
Quick Ratio
9.10

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.52 per share
Price / Book
0.59

Miscellaneous

Outstanding Shares
7,530,000
Free Float
7,354,000
Market Cap
$11.14 million
Optionable
No Data
Beta
0.70

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:BIVI) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners